Page 11 - AnnualReport2022-23
P. 11

PAR T A:  GENERAL INFORMATION




            The Wastewater Surveillance and Research Project
            (WSARP) was formalised as an SAMRC Research
            Programme. The surveillance of wastewater is being
            conducted at a total of 77 wastewater treatment
            plants in four provinces and involves four historically
            disadvantaged university partners as part of skills
            transfer and capacity development.

            An international study funded by the SAMRC and
            led by the University of KwaZulu-Natal’s (UKZN’s)
            Professor  Dhayendre  Moodley,  confirmed  the
            safe use of tenofovir disoproxil fumarate and
            emtricitabine as pre-exposure prophylaxis (PrEP) in
            pregnant women not living with HIV. Until December
            2019, pregnant and lactating women were excluded
            from the PrEP roll-out in South Africa based on the
            absence of safety data for its use in pregnancy.
            The novel study, published in The Lancet HIV, is a
            pioneering approach providing much-needed safety
            data to allow for a more informed choice during
            pregnancy  to  protect  mother  and baby  from  the
            long-term effects of HIV.
            Looking into the future, one of the key areas of focus
            for the SAMRC is the localisation of research and
            development (R&D) and the impact it has on scaling
            up innovation. We believe that localisation of R&D
            is critical to developing innovative solutions that
            are relevant and effective in addressing the health
            challenges faced by South Africans. This includes
            investing in local talent, building partnerships
            with  local institutions, and  conducting  research
            that  is  relevant  to  the  South  African  context.  We
            also support the development of local capacity
            in  research  and  innovation  through  training  and
            mentorship programmes.

            All  these achievements  could  not become
            possible without the support of our National
            Department of Health under the leadership
            of  Minister  Dr Joe  Phaahla,  our  SAMRC Board
            chaired by Professor Johnny Mahlangu, the
            Executive Committee Management, the leadership,
            researchers,  staff,  partners and  service  providers
            of the SAMRC. Thank you to all of you for making
            SAMRC a success.









            Professor Glenda E. Gray
            President and CEO: SAMRC                                     PROFESSOR GLENDA E. GRAY



                                           SAMRC  ANNUAL REPOR T 2022-23                                   9
   6   7   8   9   10   11   12   13   14   15   16